Shanghai Hile Bio-tech (603718) — Net Asset Quality Index
Shanghai Hile Bio-tech (603718) has a Net Asset Quality Index of 74.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.25 Billion minus total liabilities of CN¥312.90 Million yields net assets of CN¥936.02 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Shanghai Hile Bio-tech defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shanghai Hile Bio-tech Net Asset Quality Index Over Time (2011–2025)
This chart shows how Shanghai Hile Bio-tech's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 74.9%, representing net assets of CN¥936.02 Million against total assets of CN¥1.25 Billion CNY. Explore Shanghai Hile Bio-tech (603718) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Shanghai Hile Bio-tech (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Shanghai Hile Bio-tech from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Shanghai Hile Bio-tech worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.6% | CN¥895.97 Million | CN¥1.13 Billion | CN¥229.14 Million | ▼ -13.6 pp |
| 2024 | 93.2% | CN¥1.70 Billion | CN¥1.83 Billion | CN¥123.65 Million | ▲ +22.4 pp |
| 2023 | 70.9% | CN¥1.17 Billion | CN¥1.66 Billion | CN¥482.96 Million | ▼ -2.5 pp |
| 2022 | 73.4% | CN¥1.11 Billion | CN¥1.51 Billion | CN¥403.25 Million | ▲ +19.8 pp |
| 2021 | 53.5% | CN¥987.19 Million | CN¥1.84 Billion | CN¥856.90 Million | ▼ -0.3 pp |
| 2020 | 53.9% | CN¥962.20 Million | CN¥1.79 Billion | CN¥824.54 Million | ▼ -4.5 pp |
| 2019 | 58.3% | CN¥992.57 Million | CN¥1.70 Billion | CN¥708.72 Million | ▼ -0.3 pp |
| 2018 | 58.7% | CN¥1.03 Billion | CN¥1.75 Billion | CN¥722.81 Million | ▼ -8.4 pp |
| 2017 | 67.1% | CN¥1.07 Billion | CN¥1.60 Billion | CN¥526.83 Million | ▼ -0.8 pp |
| 2016 | 67.9% | CN¥1.01 Billion | CN¥1.48 Billion | CN¥474.55 Million | ▼ -9.7 pp |
| 2015 | 77.7% | CN¥963.31 Million | CN¥1.24 Billion | CN¥277.01 Million | ▼ -7.7 pp |
| 2014 | 85.3% | CN¥558.50 Million | CN¥654.48 Million | CN¥95.98 Million | ▲ +2.0 pp |
| 2013 | 83.3% | CN¥500.66 Million | CN¥600.84 Million | CN¥100.17 Million | ▼ -0.1 pp |
| 2012 | 83.5% | CN¥467.89 Million | CN¥560.66 Million | CN¥92.78 Million | ▲ +3.0 pp |
| 2011 | 80.5% | CN¥405.74 Million | CN¥504.03 Million | CN¥98.29 Million | — |